MC
EVH icon

Maverick Capital’s Evolent Health EVH Stock Holding History

Maverick Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.87M Buy
2,572,763
+32,833
+1% +$104K 0.07% 55
2025
Q4 		$10.2M Buy
2,539,930
+144,646
+6% +$804K 0.11% 54
2025
Q3 		$20.3M Buy
2,395,284
+1,002,760
+72% +$9.73M 0.27% 53
2025
Q2 		$15.7M Buy
+1,392,524
New +$12.8M 0.24% 50
2023
Q2 		– Sell
-11,451
Closed -$372K – 454
2023
Q1 		$372K Buy
+11,451
New +$362K 0.01% 368
2021
Q4 		– Sell
-21,130
Closed -$655K – 428
2021
Q3 		$655K Buy
+21,130
New +$507K 0.01% 399

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maverick Capital's EVH Position: Q1 2026 in Review

Maverick Capital increased its Evolent Health (EVH) stake by 1.3% in Q1 2026, buying an estimated $104K and bringing the position to 2,572,763 shares worth $5.87M. The position accounts for 0.07% of the portfolio, ranked #55.

Maverick Capital first reported a position in EVH in Q3 2021 and has held it in 6 quarters since. The position peaked at $20.3M in Q3 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Maverick Capital held 2,572,763 shares of Evolent Health worth $5.87M as of Q1 2026.
  • Maverick Capital bought 32,833 Evolent Health shares in Q1 2026, an estimated $104K.
  • Evolent Health made up 0.07% of Maverick Capital's portfolio in Q1 2026, its #55 holding.
  • Maverick Capital first reported a position in Evolent Health in Q3 2021 and has held it in 6 quarters since.
  • Maverick Capital's Evolent Health position peaked at $20.3M in Q3 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.